Seattle, WA, United States of America

David H Salinger

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: David H. Salinger: Innovator in Pharmaceutical Formulations

Introduction

David H. Salinger is a notable inventor based in Seattle, WA, with a focus on pharmaceutical innovations. He has been granted a total of four patents, showcasing his contributions to the field of medicine and treatment methodologies.

Latest Patents

Among his latest patents is a method of treating diseases using an IL-17 receptor antibody formulation. This patent relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens aimed at effectively treating various diseases. Another significant patent he holds is also centered around the IL-17 receptor antibody formulation, further emphasizing his commitment to advancing therapeutic options in healthcare.

Career Highlights

David has worked with prominent companies in the pharmaceutical industry, including Kirin-Amgen, Inc. and Amgen K-A, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to treatment.

Collaborations

Throughout his career, David has collaborated with talented individuals such as Dingjiang Liu and Holly Zhuohong Huang. These partnerships have contributed to the success of his projects and the advancement of his research.

Conclusion

David H. Salinger stands out as a significant figure in the realm of pharmaceutical inventions, with a strong portfolio of patents that reflect his dedication to improving healthcare solutions. His work continues to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…